Sonoma Pharmaceuticals (SNOA) Receivables - Other (2012 - 2016)
Sonoma Pharmaceuticals' (SNOA) quarterly Receivables - Other came in at $912000.0 in Q1 2016, up 8.19% year-on-year from $843000.0 in Q2 2015, and up 8.19% quarter-over-quarter from $843000.0 in Q1 2015.
Sonoma Pharmaceuticals (SNOA) Receivables - Other (2012 - 2016) Analysis & Trends
Sonoma Pharmaceuticals' Receivables - Other history runs 5 years deep, the most recent figure standing at $912000.0 for Q1 2016.
- On a quarterly basis, Receivables - Other rose 8.19% year-over-year to $912000.0 in Q1 2016; TTM through Mar 2016 was $912000.0, a 8.19% increase from a year earlier, with the FY2016 full-year figure at $912000.0, up 8.19% from the prior year.
- Receivables - Other grew to $912000.0 in Q1 2016 per SNOA's latest filing, from $843000.0 in the prior quarter.
- Across five years, Receivables - Other topped out at $912000.0 in Q1 2016 and bottomed at $264000.0 in Q1 2013.
- The 5-year median for Receivables - Other is $439000.0 (2012), against an average of $533142.9.
- Across the five-year window, Receivables - Other fell 8.97% in 2013 and jumped 130.68% in 2014, its largest moves.
- Year by year, Receivables - Other stood at $439000.0 in 2012, then plunged by 39.86% to $264000.0 in 2013, then surged by 130.68% to $609000.0 in 2014, then jumped by 38.42% to $843000.0 in 2015, then grew by 8.19% to $912000.0 in 2016.
- Per Business Quant, the three latest SNOA Receivables - Other figures stand at $912000.0 (Q1 2016), $843000.0 (Q1 2015), and $609000.0 (Q1 2014).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Sonoma Pharmaceuticals | 179.80 | -2.40 Mn | 2.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2016 | 912,000.00 |
| Mar 31, 2016 | 912,000.00 |
| Mar 31, 2015 | 843,000.00 |
| Mar 31, 2015 | 843,000.00 |
| Mar 31, 2014 | 609,000.00 |
| Mar 31, 2014 | 609,000.00 |
| Mar 31, 2013 | 264,000.00 |
| Mar 31, 2013 | 264,000.00 |
| Dec 31, 2012 | 439,000.00 |
| Dec 31, 2012 | 439,000.00 |
| Sep 30, 2012 | 375,000.00 |
| Sep 30, 2012 | 375,000.00 |
| Mar 31, 2012 | 290,000.00 |
| Mar 31, 2012 | 290,000.00 |